To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene ACSF3TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
229 supporting clones for gene ACSF3 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
AI929353 brain, frontal lobe .a 1 to 490 8 to 516   tiling clone,   516/516
(100 %)
16 diff
(96.9 %id)
AI929279 brain, frontal lobe .a 1828 to 2245 434 to 17   tiling clone, AAA   418/418
(100 %)
2 diff
(99.6 %id)
AI198186 anaplastic oligodendroglioma, brain .a 1913 to 2223 307 to 1       307/307
(100 %)
6 diff
(98.1 %id)
AA708701 heart .a 1954 to 2226 273 to 1   tiling clone,   273/273
(100 %)
1 diff
(99.7 %id)
BM148793 leukopheresis .b 1 to 453 1 to 457   tiling clone,   457/457
(100 %)
14 diff
(97.0 %id)
DA062861 cerebellum .b 39 to 572 2 to 535   capped   534/534
(100 %)
1 diff
(99.9 %id)
DA034802 breast .b 40 to 615 2 to 577   capped   576/576
(100 %)
2 diff
(99.7 %id)
DA765310 tongue .b 40 to 622 2 to 584   capped   583/583
(100 %)
1 diff
(99.9 %id)
DA129411 alzheimer cortex .b 45 to 521 2 to 478   capped   477/477
(100 %)
1 diff
(99.8 %id)
BC028399 Brain, hippocampus .b 65 to 2473 1 to 2427 L2P A148V V372M available from MGC, AAA   2427/2445
(99 %)
26 diff
(99.0 %id)
BG700154 brain, hippocampus .b 66 to 873 2 to 824       823/824
(99 %)
34 diff
(95.9 %id)
DA489078 brain .b 68 to 613 2 to 547   tiling clone, capped   546/546
(100 %)
0 diff
(100 %id)
DA061841 cerebellum .b 71 to 641 2 to 572   capped   571/571
(100 %)
1 diff
(99.9 %id)
DB051626 testis .b 71 to 627 2 to 559   capped   558/558
(100 %)
2 diff
(99.7 %id)
DB022464 testis .b 72 to 487 2 to 417   capped   416/416
(100 %)
1 diff
(99.8 %id)
DA370778 thalamus .b 74 to 628 2 to 556   capped   555/555
(100 %)
1 diff
(99.9 %id)
DB122592 thymus .b 76 to 618 2 to 544   capped   543/543
(100 %)
1 diff
(99.9 %id)
BQ649200 hepatocellular carcinoma, cell line, Liver .b 80 to 669 52 to 664       613/1126
(54 %)
20 diff
(98.3 %id)
TI_59385855   .b 83 to 883 80 to 912       833/1060
(78 %)
72 diff
(93.3 %id)
DA039643 bladder .b 89 to 575 2 to 488   capped   487/487
(100 %)
0 diff
(100 %id)
DA691930   .b 91 to 662 2 to 573   capped   572/572
(100 %)
1 diff
(99.9 %id)
BX404035 neuroblastoma .b 93 to 961 1 to 868   tiling clone,   868/868
(100 %)
2 diff
(99.8 %id)
AL560446 B cells (Ramos cell line), B cells from Burkitt lymphoma .b 93 to 938 1 to 866       866/866
(100 %)
21 diff
(97.6 %id)
DA654401   .b 101 to 650 2 to 551   capped   550/550
(100 %)
1 diff
(99.9 %id)
BM544528 brain, hippocampus .b 103 to 1108 17 to 1042       1026/1044
(98 %)
40 diff
(96.2 %id)
DA037534   .b 105 to 650 2 to 547   capped   546/546
(100 %)
1 diff
(99.9 %id)
TI_57200604   .b 105 to 926 61 to 899       839/899
(93 %)
32 diff
(96.5 %id)
TI_57200679   .b 106 to 743 28 to 698       671/843
(79 %)
33 diff
(96.1 %id)
BM005908 hepatocellular carcinoma, cell line, Liver .b 111 to 883 1 to 805       805/953
(84 %)
68 diff
(92.9 %id)
CV575622 cornea, eye .b 112 to 712 1 to 620       620/620
(100 %)
16 diff
(97.5 %id)
BI821453 pooled brain, lung, testis .b 113 to 926 1 to 831       831/831
(100 %)
26 diff
(96.9 %id)
BI821527 pooled brain, lung, testis .b 113 to 743 1 to 664       664/809
(82 %)
28 diff
(96.6 %id)
BI916694 brain .b 116 to 879 1 to 788       788/788
(100 %)
22 diff
(97.3 %id)
TI_57240180   .b 116 to 879 29 to 816       788/816
(96 %)
28 diff
(96.6 %id)
BI911513 leukocyte .b 117 to 746 1 to 695       589/781
(75 %)
55 diff
(93.0 %id)
TI_57232853   .b 117 to 746 1 to 695       589/781
(75 %)
55 diff
(93.0 %id)
BU184310 eye, retinoblastoma .b 123 to 970 1 to 876       876/892
(98 %)
14 diff
(98.5 %id)
TI_57233397   .b 131 to 790 26 to 703       678/703
(96 %)
25 diff
(96.5 %id)
BI906921 leukocyte .b 135 to 790 1 to 674       674/674
(100 %)
22 diff
(96.8 %id)
CN400232 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 145 to 504 1 to 375       379/375
(101 %)
17 diff
(95.5 %id)
BX447740 T cells (Jurkat cell line) .b 145 to 1139 1 to 988   tiling clone,   988/1033
(95 %)
22 diff
(97.9 %id)
BE882853 leiomyosarcoma, uterus .b 164 to 745 1 to 601       601/601
(100 %)
18 diff
(97.1 %id)
AL581888 B cells (Ramos cell line), B cells from Burkitt lymphoma .b 1745 to 2473 729 to 1   tiling clone,   729/729
(100 %)
19 diff
(97.4 %id)
BX447739 T cells (Jurkat cell line) .b 1745 to 2472 734 to 1   tiling clone,   734/734
(100 %)
26 diff
(96.5 %id)
NM_001127214.1   .c 1 to 2283 2 to 2284 exact RefSeq,   2284/2284
(100 %)
0 diff
(100 %id)
DA370781 thalamus .c 4 to 536 2 to 534   tiling clone, capped   533/533
(100 %)
0 diff
(100 %id)
BX360012 Placenta Cot 25-normalized .c 13 to 666 1 to 668       668/668
(100 %)
42 diff
(93.8 %id)
BX402632 Placenta Cot 25-normalized .c 13 to 881 1 to 867       867/867
(100 %)
9 diff
(99.0 %id)
DA996358   .c 32 to 568 2 to 539   capped   538/538
(100 %)
2 diff
(99.7 %id)
AK290963   .c 37 to 2283 1 to 2251 exact tiling clone,   2251/2251
(100 %)
3 diff
(99.9 %id)
DA699098   .c 38 to 513 2 to 477   capped   476/476
(100 %)
0 diff
(100 %id)
DN999624   .c 48 to 642 1 to 595       595/595
(100 %)
3 diff
(99.5 %id)
CN400234 embryonic stem cells, cell lines H1, H7, andH9 .c 98 to 690 1 to 612       612/612
(100 %)
15 diff
(97.6 %id)
BM542546 embryonal carcinoma, cell line, testis .c 101 to 859 1 to 785       785/1092
(71 %)
64 diff
(94.2 %id)
NM_174917.2   .d 1 to 3624 2 to 3625 exact RefSeq,   3625/3625
(100 %)
2 diff
(100.0 %id)
DB108061 thymus .d 20 to 588 2 to 570   tiling clone, capped   569/569
(100 %)
1 diff
(99.9 %id)
AK075499 whole embryo, mainly head .d 70 to 3624 1 to 3555 K278E tiling clone,   3555/3555
(100 %)
5 diff
(99.9 %id)
DA568746 whole embryo, mainly head .d 71 to 733 2 to 663   capped   662/662
(100 %)
3 diff
(99.6 %id)
AA310170   .d 241 to 569 8 to 336       329/336
(97 %)
9 diff
(97.4 %id)
AW401881 lymph .d 253 to 576 1 to 343       343/343
(100 %)
17 diff
(95.1 %id)
BE243847 leukopheresis .d 256 to 576 1 to 340       340/340
(100 %)
14 diff
(95.9 %id)
BE246304 leukopheresis .d 256 to 627 1 to 390       391/390
(100 %)
15 diff
(96.2 %id)
BM152773 leukopheresis .d 256 to 650 1 to 414       414/414
(100 %)
15 diff
(96.4 %id)
BM909413 lymph, lymphoma, cell line .d 259 to 1085 19 to 853       835/1098
(76 %)
28 diff
(97.5 %id)
TI_154138089   .d 259 to 833 71 to 663       593/594
(99 %)
14 diff
(97.7 %id)
BX364062   .d 267 to 1286 1 to 1031       1031/1055
(97 %)
27 diff
(97.5 %id)
BM909397 lymph, lymphoma, cell line .d 269 to 950 1 to 682       682/1103
(61 %)
16 diff
(98.6 %id)
BQ062808 lymph, lymphoma, cell line .d 272 to 1121 32 to 903       872/1062
(82 %)
31 diff
(97.1 %id)
BQ055997 lymph, lymphoma, cell line .d 273 to 1009 1 to 759       759/1117
(67 %)
14 diff
(98.8 %id)
BF883921 lung_tumor .d 326 to 880 16 to 569       554/569
(97 %)
6 diff
(99.0 %id)
CN400231 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .d 449 to 1123 1 to 674       674/674
(100 %)
7 diff
(99.0 %id)
BF182630 large cell carcinoma, lung .d 509 to 1246 1 to 737       737/870
(84 %)
28 diff
(96.8 %id)
DA082897 cerebellum .d 678 to 1267 2 to 591   capped   590/590
(100 %)
3 diff
(99.5 %id)
DB130255 thymus .d 678 to 1252 2 to 576   capped   575/575
(100 %)
3 diff
(99.5 %id)
CN400235 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .d 752 to 1391 1 to 640       640/640
(100 %)
1 diff
(99.9 %id)
BM479998 embryonal carcinoma, cell line, testis .d 795 to 1717 1 to 932       932/1032
(90 %)
25 diff
(97.6 %id)
BG759715 B-cells, primary B-cells from tonsils (cell line) .d 818 to 1377 1 to 559       559/559
(100 %)
4 diff
(99.3 %id)
BF528771 anaplastic oligodendroglioma with 1p/19qloss, brain .d 887 to 1543 1 to 660       662/942
(70 %)
27 diff
(97.2 %id)
AA852502 Bone, Hip .d 938 to 1047 9 to 116       108/116
(93 %)
6 diff
(94.9 %id)
CR606678 T cells (Jurkat cell line) .d 1005 to 2430 1 to 1426   tiling clone,   1426/1426
(100 %)
0 diff
(100 %id)
AL557299 T cells (Jurkat cell line), T cells from T cell leukemia .d 1005 to 1786 1 to 782   fully sequenced,   782/782
(100 %)
0 diff
(100 %id)
CR624745 T cells (Jurkat cell line) Cot10-normalized .d 1008 to 2417 1 to 1410       1410/1410
(100 %)
0 diff
(100 %id)
BX325026   .d 1008 to 1786 1 to 778   fully sequenced,   778/778
(100 %)
4 diff
(99.5 %id)
BF976393 B-cells, primary B-cells from tonsils (cell line) .d 1122 to 1585 1 to 470       470/1092
(43 %)
13 diff
(98.9 %id)
BI018053 lung_tumor .d 1207 to 1411 1 to 206       206/206
(100 %)
4 diff
(98.1 %id)
AA251198 germinal center B cell .d 1240 to 1467 1 to 228       228/238
(95 %)
2 diff
(99.2 %id)
BM923262 pooled colon, kidney, stomach .d 1275 to 2286 14 to 1035       1022/1042
(98 %)
31 diff
(97.1 %id)
CA488846   .d 1308 to 2102 1 to 807       807/940
(85 %)
34 diff
(96.4 %id)
BE781502 eye, retinoblastoma .d 1340 to 2149 1 to 805       805/856
(94 %)
21 diff
(97.6 %id)
BI199906 brain, neuroblastoma .d 1461 to 2132 1 to 670       670/671
(99 %)
11 diff
(98.4 %id)
CN400233 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .d 1464 to 1941 1 to 478       478/478
(100 %)
5 diff
(99.0 %id)
CV349686 nervous_tumor .d 1480 to 1935 23 to 479       457/569
(80 %)
10 diff
(98.3 %id)
BX464576 B cells (Ramos cell line) .d 1574 to 2282 1 to 710       710/710
(100 %)
45 diff
(93.7 %id)
CB160094 Liver .d 1670 to 2135 1 to 466       466/466
(100 %)
2 diff
(99.6 %id)
BM709081 eye, optic nerve .d 1670 to 1871 1 to 202   fully sequenced,   202/202
(100 %)
0 diff
(100 %id)
BX383045   .d 1703 to 2414 711 to 1       711/711
(100 %)
6 diff
(99.2 %id)
BX364061   .d 1703 to 2391 698 to 12       687/698
(98 %)
0 diff
(100 %id)
BQ233385 epithelioid carcinoma, Pancreas .d 1705 to 2449 777 to 24   AAA Submitted on the opposite strand 754/832
(90 %)
12 diff
(98.6 %id)
BQ015385 Chondrosarcoma, Left Pubic Bone .d 1709 to 2449 759 to 15   AAA   745/745
(100 %)
2 diff
(99.8 %id)
TI_154038851   .d 1717 to 2449 835 to 105   AAA   731/778
(93 %)
15 diff
(98.1 %id)
BX102417   .d 1730 to 2315 1 to 587       587/587
(100 %)
1 diff
(99.9 %id)
BU634068 cell lines, Chondrosarcoma .d 1755 to 2449 716 to 19   AAA   698/698
(100 %)
1 diff
(99.9 %id)
AL579367 T cells (Jurkat cell line), T cells from T cell leukemia .d 1756 to 2400 675 to 31   fully sequenced, AAA   645/653
(98 %)
0 diff
(100 %id)
BX325025   .d 1756 to 2417 662 to 1   fully sequenced,   662/662
(100 %)
0 diff
(100 %id)
CA306525 Alveolar Macrophage, lung .d 1757 to 2449 711 to 15   AAA   697/697
(100 %)
0 diff
(100 %id)
AW025904 thymus, pooled .d 1786 to 2448 674 to 1       674/674
(100 %)
17 diff
(97.5 %id)
BI868332 adenocarcinoma, cell line, Liver .d 1789 to 2448 1 to 664       664/676
(98 %)
9 diff
(98.7 %id)
TI_57227987   .d 1793 to 2448 61 to 720       660/805
(81 %)
21 diff
(97.4 %id)
BU732540 eye, optic nerve .d 1823 to 2462 661 to 19   fully sequenced, AAA   643/643
(100 %)
3 diff
(99.6 %id)
CA314849 Human Lung Epithelial cells, lung .d 1832 to 2449 636 to 15   AAA   622/622
(100 %)
0 diff
(100 %id)
AW008529 thymus, pooled .d 1833 to 2452 623 to 1       623/632
(98 %)
9 diff
(98.6 %id)
TI_154132500   .d 1833 to 2451 724 to 98       627/1046
(59 %)
16 diff
(98.5 %id)
CA444919 lung, Metastatic Chondrosarcoma .d 1910 to 2449 558 to 15   AAA   544/544
(100 %)
0 diff
(100 %id)
BG820676 anaplastic oligodendroglioma with 1p/19qloss, brain .d 1949 to 2449 1 to 506       506/524
(96 %)
8 diff
(98.5 %id)
BM693949 eye, Retina Foveal and Macular .d 1962 to 2431 1 to 470       470/484
(97 %)
2 diff
(99.6 %id)
AI743467 pooled .d 1975 to 2431 480 to 22       459/480
(95 %)
0 diff
(100 %id)
AI680826 carcinoid, lung .d 1978 to 2451 478 to 2       477/478
(99 %)
0 diff
(100 %id)
BQ722189 sympathetic trunk .d 1978 to 2431 1 to 454   AAA   454/472
(96 %)
1 diff
(99.8 %id)
AA251134 germinal center B cell .d 2014 to 2426 412 to 1       412/412
(100 %)
4 diff
(99.1 %id)
AI083911 anaplastic oligodendroglioma, brain .d 2018 to 2450 437 to 1       437/437
(100 %)
0 diff
(100 %id)
AI950071 anaplastic oligodendroglioma, brain .d 2022 to 2449 432 to 1       432/432
(100 %)
6 diff
(98.7 %id)
AA742963 germinal center B cell .d 2032 to 2366 333 to 1       333/333
(100 %)
2 diff
(99.4 %id)
BM709008 eye, RPE and Choroid .d 2051 to 2450 1 to 404       404/427
(94 %)
3 diff
(99.3 %id)
BQ018322 lung, Metastatic Chondrosarcoma .d 2058 to 2449 410 to 15   AAA   396/396
(100 %)
0 diff
(100 %id)
AW575090 lymph .d 2064 to 2431 403 to 36   AAA   368/386
(95 %)
0 diff
(100 %id)
AI015927   .d 2065 to 2451 392 to 2       391/392
(99 %)
0 diff
(100 %id)
AA805175 germinal center B cell .d 2081 to 2431 397 to 48   AAA   350/368
(95 %)
0 diff
(100 %id)
AA516361 colon .d 2102 to 2447 350 to 1       350/350
(100 %)
0 diff
(100 %id)
AA603773 breast .d 2113 to 2449 396 to 56   AAA   341/341
(100 %)
0 diff
(100 %id)
BE245902 leukopheresis .d 2123 to 2445 334 to 6       329/334
(98 %)
0 diff
(100 %id)
AA852503 Bone, Hip .d 2134 to 2431 303 to 8       296/303
(97 %)
0 diff
(100 %id)
AA953720 carcinoid, lung .d 2137 to 2448 316 to 1       316/316
(100 %)
0 diff
(100 %id)
AI701937 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .d 2158 to 2437 296 to 17       280/296
(94 %)
6 diff
(98.0 %id)
BQ018600 lung, Metastatic Chondrosarcoma .d 2164 to 2458 317 to 19   AAA   299/300
(99 %)
11 diff
(96.4 %id)
AI873898 serous papillary carcinoma, high grade, 2pooled tumors, uterus .d 2199 to 2451 258 to 3       256/258
(99 %)
0 diff
(100 %id)
AA687875 normal prostate, Prostate .d 2203 to 2451 255 to 4       252/255
(98 %)
0 diff
(100 %id)
AW131728 brain, medulloblastoma .d 2225 to 2451 238 to 7       232/238
(97 %)
0 diff
(100 %id)
AA931078 Kidney .d 2232 to 2448 222 to 3       220/222
(99 %)
0 diff
(100 %id)
AW204102   .d 2301 to 2449 166 to 14   AAA   153/162
(94 %)
2 diff
(98.8 %id)
AA948773   .d 2303 to 2451 154 to 3       152/168
(90 %)
0 diff
(100 %id)
DB355298 whole embryo, mainly head .d 3161 to 3621 460 to 4       457/461
(99 %)
0 diff
(100 %id)
BC072391 Brain, hippocampus .e 1 to 2420 1 to 2439 L2P A17P tiling clone, available from MGC, AAA   2439/2457
(99 %)
20 diff
(99.2 %id)
CR615543 B cells (Ramos cell line) Cot 25-normalized .f 1 to 2024 1 to 2024 exact tiling clone,   2024/2024
(100 %)
0 diff
(100 %id)
DA492949 brain .f 819 to 1397 2 to 580   capped   579/579
(100 %)
0 diff
(100 %id)
BX328302   .f 845 to 1573 1 to 727       727/727
(100 %)
8 diff
(98.9 %id)
NR_023316.1   .g 1 to 1586 2 to 1587 exact RefSeq, tiling clone, AAA   1587/1587
(100 %)
0 diff
(100 %id)
BM806381 melanotic melanoma, skin .g 41 to 853 1 to 815   available from MGC,   815/972
(83 %)
18 diff
(98.2 %id)
BC064609 Skin, melanotic melanoma. .g 51 to 1572 1 to 1522   available from MGC, AAA   1522/1540
(98 %)
3 diff
(99.9 %id)
CR623892 fetal liver .h 1 to 1435 1 to 1435 exact tiling clone,   1435/1435
(100 %)
0 diff
(100 %id)
BX406116 fetal liver, Liver .h 1 to 876 1 to 871   fully sequenced,   871/871
(100 %)
5 diff
(99.5 %id)
BX448529 fetal liver, Liver .h 815 to 1435 622 to 1   fully sequenced,   622/622
(100 %)
8 diff
(98.8 %id)
DB030484 testis .i 1 to 549 2 to 551   tiling clone, capped   550/550
(100 %)
2 diff
(99.7 %id)
BG397849 B-cells, primary B-cells from tonsils (cell line) .i 220 to 1152 1 to 927 V107M K156Q E157G E159G L160A ... tiling clone,   927/1018
(91 %)
24 diff
(97.7 %id)
BX382891   .j 1 to 985 1 to 982   tiling clone,   982/988
(99 %)
45 diff
(95.5 %id)
BG748268 eye, normal pigmented retinal epithelium .k 1 to 851 1 to 848   tiling clone,   848/848
(100 %)
16 diff
(98.2 %id)
BQ953430 eye, normal pigmented retinal epithelium .k 3 to 795 1 to 806   tiling clone,   806/920
(87 %)
14 diff
(98.5 %id)
BX366466 Neuroblastoma Cot 25-normalized .k 35 to 830 1 to 796   tiling clone,   796/796
(100 %)
13 diff
(98.4 %id)
F08785 brain, total brain .k 75 to 393 1 to 319       319/319
(100 %)
3 diff
(99.1 %id)
BX366465 Neuroblastoma Cot 25-normalized .k 940 to 1577 643 to 6   tiling clone,   638/643
(99 %)
5 diff
(99.3 %id)
Z41828 brain, total brain .k 1395 to 1626 236 to 1   tiling clone,   236/236
(100 %)
3 diff
(98.8 %id)
BE397772 Burkitt lymphoma, lymph .l 1 to 713 36 to 740 V119M tiling clone,   705/838
(84 %)
19 diff
(97.8 %id)
BE270711 Burkitt lymphoma, lymph .l 6 to 714 31 to 730       700/793
(88 %)
18 diff
(97.8 %id)
BU620517 cell lines, Chondrosarcoma .l 276 to 939 682 to 19   tiling clone, AAA   664/664
(100 %)
1 diff
(99.9 %id)
AA776933   .l 644 to 1053 1 to 408   tiling clone, Submitted on the opposite strand 408/408
(100 %)
4 diff
(99.1 %id)
AW962302   .l 669 to 946 279 to 2     Submitted on the opposite strand 278/279
(99 %)
0 diff
(100 %id)
AK090408 Spleen .m-u 1 to 5324 1 to 5320   tiling clone, available from FLJ,   5320/5320
(100 %)
22 diff
(99.6 %id)
BG986140 denis_drash .m-u 780 to 930 1 to 151   tiling clone,   151/151
(100 %)
6 diff
(96.1 %id)
AW866034 stomach_normal .m-u 1267 to 1604 14 to 347   tiling clone,   334/347
(96 %)
6 diff
(98.3 %id)
DA072296 cerebellum .m-u 1507 to 2079 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
DA929371 small intestine .m-u 1524 to 2097 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
DB146554 thymus .m-u 1637 to 2190 2 to 555   capped   554/554
(100 %)
0 diff
(100 %id)
CR740329 pooled .m-u 1652 to 2057 1 to 406       406/406
(100 %)
0 diff
(100 %id)
BF370148 prostate_normal .m-u 1850 to 1981 132 to 1       132/133
(99 %)
0 diff
(100 %id)
BG756553 B-cells, primary B-cells from tonsils (cell line) .m-u 2165 to 2935 1 to 767       767/770
(99 %)
5 diff
(99.4 %id)
AI674691 pooled .m-u 2291 to 2817 527 to 1       527/527
(100 %)
3 diff
(99.5 %id)
DB159487 thymus .m-u 2312 to 2888 2 to 578   capped   577/577
(100 %)
0 diff
(100 %id)
DA441234 tongue, tumor tissue .m-u 2496 to 3086 2 to 592   capped   591/591
(100 %)
0 diff
(100 %id)
DA895816 skeletal muscle .m-u 2567 to 3111 2 to 546   capped   545/545
(100 %)
0 diff
(100 %id)
BX464713 thymus .m-u 2930 to 3867 935 to 1   tiling clone, Submitted on the opposite strand 935/935
(100 %)
16 diff
(98.3 %id)
AA010924 heart .m-u 3000 to 3431 1 to 445   fully sequenced,   445/445
(100 %)
11 diff
(97.6 %id)
BX109454 heart .m-u 3001 to 3768 1 to 768   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 768/772
(99 %)
3 diff
(99.7 %id)
AI763000 B-cell, chronic lymphotic leukemia .m-u 3074 to 3780 700 to 1       700/862
(81 %)
38 diff
(95.6 %id)
BQ007827 Chondrosarcoma, Left Pelvis .m-u 3077 to 3786 722 to 12   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 711/722
(98 %)
0 diff
(100 %id)
AW303189 invasive adenocarcinoma, lung .m-u 3108 to 3526 26 to 443     Submitted on the opposite strand 418/443
(94 %)
6 diff
(98.7 %id)
AI346836 adenocarcinoma, colon .m-u 3210 to 3779 571 to 1       571/571
(100 %)
3 diff
(99.5 %id)
AA708692 heart .m-u 3299 to 3760 462 to 1       462/462
(100 %)
0 diff
(100 %id)
AI568399 B-cell, chronic lymphotic leukemia .m-u 3335 to 3786 452 to 1       452/452
(100 %)
0 diff
(100 %id)
AI083883 anaplastic oligodendroglioma, brain .m-u 3336 to 3757 422 to 1       422/422
(100 %)
1 diff
(99.8 %id)
BQ002205 Chondrosarcoma, Left Pelvis .m-u 3344 to 3786 454 to 12   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 443/454
(97 %)
0 diff
(100 %id)
DB108127 thymus .m-u 3353 to 3923 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
BE676769 B-cell, chronic lymphotic leukemia .m-u 3367 to 3780 414 to 1       414/414
(100 %)
1 diff
(99.8 %id)
BF508503   .m-u 3396 to 3786 401 to 11   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 391/401
(97 %)
0 diff
(100 %id)
AA011312 heart .m-u 3401 to 3760 362 to 1   fully sequenced,   362/362
(100 %)
6 diff
(98.4 %id)
AI248227 liver and spleen .m-u 3423 to 3782 363 to 4       360/363
(99 %)
0 diff
(100 %id)
W95600 heart .m-u 3633 to 3903 1 to 269       269/271
(99 %)
5 diff
(98.2 %id)
W04883 lung .m-u 4325 to 4788 1 to 457       457/457
(100 %)
8 diff
(98.3 %id)
CR742986 lung .m-u 4326 to 5026 1 to 703   tiling clone,   703/703
(100 %)
6 diff
(99.2 %id)
AK098113 trachea .m-u 4422 to 7020 1 to 2603 exact tiling clone, available from FLJ,   2603/2603
(100 %)
20 diff
(99.3 %id)
DB199238 trachea .m-u 4423 to 5015 2 to 595   capped   594/594
(100 %)
17 diff
(97.2 %id)
DB121169 thymus .m-u 4459 to 5012 2 to 555   capped   554/554
(100 %)
23 diff
(95.9 %id)
BX416002 thymus .m-u 4518 to 4671 157 to 1     Submitted on the opposite strand 967/995
(97 %)
35 diff
(96.5 %id)
BF854021 lung_normal .m-u 4761 to 5073 106 to 424   tiling clone,   319/424
(75 %)
6 diff
(98.6 %id)
BE928094 colon .m-u 4774 to 5115 84 to 425   tiling clone,   342/425
(80 %)
6 diff
(98.6 %id)
DB313722 tongue, tumor tissue .m-u 4796 to 5313 519 to 1       519/519
(100 %)
5 diff
(99.1 %id)
DB343111 thymus .m-u 4829 to 5313 485 to 1       485/487
(99 %)
15 diff
(97.0 %id)
N70582 lung .m-u 4876 to 5317 443 to 1       443/443
(100 %)
6 diff
(98.7 %id)
BM706661 eye, optic nerve .m-u 4928 to 5195 9 to 276   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 268/454
(59 %)
3 diff
(99.4 %id)
AI832360 colon .m-u 5014 to 5311 299 to 1       299/299
(100 %)
12 diff
(96.0 %id)
W95601 heart .m-u 5065 to 5314 251 to 1       251/252
(99 %)
1 diff
(99.7 %id)
DA465875   .m-u 5100 to 5525 2 to 428   tiling clone, capped   427/427
(100 %)
2 diff
(99.6 %id)
AW082518 esophagus, squamous cell carcinoma .m-u 5146 to 5324 180 to 1       180/180
(100 %)
1 diff
(99.5 %id)
AW875041 pnet .m-u 5332 to 5795 466 to 3       464/479
(96 %)
0 diff
(100 %id)
AA355089   .m-u 5340 to 5615 1 to 277       277/277
(100 %)
3 diff
(99.0 %id)
BF367058 placenta_normal .m-u 5473 to 5784 334 to 24       311/335
(92 %)
0 diff
(100 %id)
EB387243 eye, optic nerve .m-u 6153 to 6966 1 to 814 exact     814/814
(100 %)
0 diff
(100 %id)
TI_149296981   .m-u 6206 to 7020 883 to 79 exact AAA   805/917
(87 %)
17 diff
(98.2 %id)
TI_154041804   .m-u 6206 to 7016 899 to 90 H119X AAA   810/1003
(80 %)
13 diff
(98.8 %id)
BM982125 lung, Primary Lung Cystic Fibrosis EpithelialCells .m-u 6330 to 7020 708 to 15 exact tiling clone, AAA   694/694
(100 %)
3 diff
(99.6 %id)
BQ447095 Knee, Osteoarthritic Cartilage .m-u 6373 to 7002 666 to 37 S47F H119Y AAA   630/648
(97 %)
0 diff
(100 %id)
AW976359   .m-u 6440 to 7002 581 to 18 W15*   Submitted on the opposite strand 564/581
(97 %)
0 diff
(100 %id)
DB348263 trachea .m-u 6484 to 7020 541 to 1 exact     541/541
(100 %)
0 diff
(100 %id)
CD672719 eye, Iris .n 1 to 581 1 to 580 R108G tiling clone,   580/580
(100 %)
3 diff
(99.5 %id)
AA310596   .o 1 to 434 1 to 435 E44X D90X R93A A94V V95Q ... tiling clone,   435/436
(99 %)
4 diff
(99.1 %id)
BF925186 nervous_tumor .p 1 to 485 510 to 26 A20T G99A R100T E117* tiling clone, Submitted on the opposite strand 485/510
(95 %)
1 diff
(99.9 %id)
BU193564 testis .q-u 1 to 428 2 to 431 R90I P97S P103A A104G S106V ... tiling clone,   431/891
(48 %)
12 diff
(98.7 %id)
CN266890 embryonic stem cells, cell lines H1, H7, andH9 .r 1 to 406 7 to 414 L38F D39W G40M V41E L43R ... tiling clone,   412/427
(96 %)
7 diff
(98.4 %id)
DB142954 thymus .s 1 to 504 2 to 505 M70V tiling clone, capped   504/504
(100 %)
4 diff
(99.3 %id)
DB345510 thymus .s 2976 to 3178 204 to 1   tiling clone,   204/204
(100 %)
3 diff
(98.6 %id)
AK096561 brain .t 1 to 2495 2 to 2494 exact tiling clone, available from FLJ,   2494/2494
(100 %)
6 diff
(99.8 %id)
DA774446 brain .t 1 to 570 2 to 571 exact capped   570/570
(100 %)
0 diff
(100 %id)
TI_149301932   .t 1524 to 2401 955 to 84   AAA   872/956
(91 %)
10 diff
(99.0 %id)
BM980210 lung, Primary Lung Cystic Fibrosis EpithelialCells .t 1664 to 2401 756 to 19   AAA   738/738
(100 %)
0 diff
(100 %id)
CR976321 T-Lymphocytes .t 1680 to 2256 1 to 578       578/580
(99 %)
2 diff
(99.7 %id)
AI580113 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .t 1932 to 2412 485 to 5   tiling clone,   481/485
(99 %)
0 diff
(100 %id)
DB325905 brain .t 1942 to 2495 552 to 1   tiling clone,   552/552
(100 %)
2 diff
(99.7 %id)
EH315313   .t 2464 to 2513 50 to 1   tiling clone, Submitted on the opposite strand 50/50
(100 %)
0 diff
(100 %id)
BI837487 pooled pancreas and spleen .u 1 to 848 1 to 848 exact tiling clone,   848/850
(99 %)
12 diff
(98.6 %id)
TI_57165699   .u 1 to 848 35 to 882 exact     848/884
(95 %)
17 diff
(98.1 %id)
BM151727 leukopheresis .va 1 to 373 7 to 379 P4R D19F P22L K33M tiling clone,   379/482
(78 %)
9 diff
(98.2 %id)
BM151932 leukopheresis .va 1 to 472 7 to 497 P4R A21V P22S tiling clone,   497/497
(100 %)
23 diff
(95.4 %id)
AK056664 brain Gene ACSF3, variant not shown       available from FLJ, Suspected internal deletion, this clone was ignored    
BF943761 nervous_normal Gene ACSF3, variant not shown         Submitted on the opposite strand, submitted on the opposite strand    
DW414847 Liver Gene ACSF3, variant not shown         Suspected internal deletion, this clone was ignored    
AI401103 Prostate Gene ACSF3, variant not shown         Suspected internal deletion, this clone was ignored    
CB049622 Prostate Gene ACSF3, variant not shown       fully sequenced, AAA Suspected internal deletion, this clone was ignored    
CB049623 Prostate Gene ACSF3, variant not shown       fully sequenced, AAA Suspected internal deletion, this clone was ignored    
BF002022 colon, colon tumor, RER+ Gene ACSF3, variant not shown         This clone was ignored    
DB325618 brain Gene ACSF3, variant not shown         Suspected internal deletion, this clone was ignored    
DA768943 brain Gene ACSF3, variant not shown       capped Suspected internal deletion, this clone was ignored    
DA951914 Spleen Gene ACSF3, variant not shown       capped This clone was ignored    
DB333805 Spleen Gene ACSF3, variant not shown         This clone was ignored    
BM193171 leukopheresis Gene ACSF3, variant not shown         This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m-u, .n, .o, .p, .q-u, .r, .s, .t, .u, .va Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes C